Compile Data Set for Download or QSAR
Report error Found 8 of ic50 for monomerid = 313803
TargetBromodomain-containing protein 4(Human)
Walter and Eliza Hall Institute of Medical Research

Curated by ChEMBL
LigandPNGBDBM313803(US10167292, Example 47)
Affinity DataIC50: 11nMAssay Description:Inhibition of human His-tagged Brd4 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinyla...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2020
Entry Details Article
PubMed
TargetBromodomain-containing protein 4(Human)
Walter and Eliza Hall Institute of Medical Research

Curated by ChEMBL
LigandPNGBDBM313803(US10167292, Example 47)
Affinity DataIC50: 13nMAssay Description:Inhibition of human His-tagged Brd4 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinyla...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2020
Entry Details Article
PubMed
TargetBromodomain-containing protein 2(Human)
Walter and Eliza Hall Institute of Medical Research

Curated by ChEMBL
LigandPNGBDBM313803(US10167292, Example 47)
Affinity DataIC50: 24nMAssay Description:Inhibition of human His-tagged Brd2 bromodomain 2 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinyla...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2020
Entry Details Article
PubMed
TargetBromodomain-containing protein 2(Human)
Walter and Eliza Hall Institute of Medical Research

Curated by ChEMBL
LigandPNGBDBM313803(US10167292, Example 47)
Affinity DataIC50: 56nMAssay Description:Inhibition of human His-tagged Brd2 bromodomain 1 expressed in Escherichia coli BL21 (DE3) preincubated for 30 mins followed by addition of biotinyla...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2020
Entry Details Article
PubMed
TargetBromodomain-containing protein 2 [91-163](Human)
Catalyst Therapeutics

US Patent
LigandPNGBDBM313803(US10167292, Example 47)
Affinity DataIC50: 100nMAssay Description:BRD binding and inhibition was assessed by measuring the interaction of biotinylated acetyl-histone H4 peptide (Anaspec #64989) with the BRD target p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2019
Entry Details
Go to US Patent

TargetBromodomain-containing protein 2 [364-436](Human)
Catalyst Therapeutics

US Patent
LigandPNGBDBM313803(US10167292, Example 47)
Affinity DataIC50: 100nMAssay Description:BRD binding and inhibition was assessed by measuring the interaction of biotinylated acetyl-histone H4 peptide (Anaspec #64989) with the BRD target p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2019
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [75-147](Human)
Catalyst Therapeutics

US Patent
LigandPNGBDBM313803(US10167292, Example 47)
Affinity DataIC50: 100nMAssay Description:BRD binding and inhibition was assessed by measuring the interaction of biotinylated acetyl-histone H4 peptide (Anaspec #64989) with the BRD target p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2019
Entry Details
Go to US Patent

TargetBromodomain-containing protein 4 [368-440](Human)
Catalyst Therapeutics

US Patent
LigandPNGBDBM313803(US10167292, Example 47)
Affinity DataIC50: 100nMAssay Description:BRD binding and inhibition was assessed by measuring the interaction of biotinylated acetyl-histone H4 peptide (Anaspec #64989) with the BRD target p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2019
Entry Details
Go to US Patent